Research reviewed by Gram suggests blueberries contain compounds that slow cancer cell growth in lab and animal studies, covering breast, lung, ovarian, and colorectal cancers. However, no human clinical trials have confirmed that blueberries can prevent or treat cancer. Eating blueberries is a healthy choice, but they should not replace medical care.
According to research reviewed by Gram, blueberries contain natural plant compounds that may slow cancer cell growth, but the evidence so far comes from lab dishes and animals, not people. In this review, scientists examined published preclinical studies from major research databases. These studies suggest that blueberry compounds, such as anthocyanins, may affect cell signals that control growth and cell death. In lab tests, the compounds slowed the growth of breast, lung, ovarian, and colorectal cancer cells. In animal studies, blueberry diets were linked to smaller tumors. The authors stress that no clinical trials in people have been completed yet, and that the body may not absorb these compounds well. Blueberries are a healthy food, but they are not a proven way to prevent or treat cancer. Human studies are needed before firm conclusions can be drawn.
Key Statistics
A 2026 review published in Food & Function found that blueberry compounds slowed tumor cell growth and triggered cell death in breast, lung, ovarian, and colorectal cancer cells in laboratory studies.
The 2026 review, which drew on studies from PubMed, ScienceDirect, Scopus, and Web of Science, found no clinical trials testing blueberries in people for cancer prevention or treatment.
The Quick Take
- What they studied: Scientists wanted to know whether blueberries, and the natural plant compounds in them, can help prevent cancer or slow its growth. They reviewed earlier lab and animal studies to see what those experiments have found so far.
- Who participated: This was a review of previously published studies rather than a new experiment with people. The review looked at lab tests on cancer cells and experiments in animals. No human volunteers took part, and the number of participants in the combined studies was not reported in a single total.
- Key finding: Blueberry compounds slowed cancer cell growth and encouraged cell death in lab tests across several cancer types, including breast, lung, ovarian, and colorectal cancers. Animal studies also found that blueberry diets were linked to smaller tumors. However, no clinical trials in people were found, so these results cannot yet be applied to human health.
- What it means for you: Blueberries are a nutritious food that can be part of a healthy diet, and the early findings are encouraging. However, they should not be seen as a cancer treatment or a guaranteed way to prevent cancer. Continue following recommended cancer screenings and talk with your doctor about your personal risk.
The Research Details
This research is a critical review, which means the authors gathered and carefully evaluated earlier studies on a topic. They searched four major research databases, PubMed, ScienceDirect, Scopus, and Web of Science, to find relevant papers. Their goal was to understand how blueberries may affect cancer at a cellular and molecular level.
The studies reviewed were mostly preclinical, meaning they were done in test tubes, petri dishes, or animals before any testing in people. Lab studies, called in vitro studies, looked at how blueberry compounds affect cancer cells grown in dishes. Animal studies, called in vivo studies, looked at whether blueberry-rich diets could slow tumor growth in living organisms.
Because the authors reviewed many different experiments, they could spot patterns across studies. They also pointed out gaps, such as cancer types that have been studied in animals only a few times, and differences in how blueberry products were prepared.
Lab and animal studies are an important first step because they show what might happen in the body and help scientists choose which ideas deserve testing in people. A review like this combines many small experiments, so it can reveal whether results are consistent or only appear in a single study.
However, these methods have clear limits. What happens in a petri dish does not always happen inside a human body, where food is digested and compounds are broken down. That is why the authors emphasize that this type of research can point toward possibilities but cannot prove what blueberries do for people.
This review draws on published research from respected databases, and the authors openly describe the limits of the evidence. Their conclusions are careful and do not claim that blueberries cure or prevent cancer.
Readers should keep in mind that reviews depend on the quality of the studies they include. Many lab and animal experiments differ in how they were designed, what blueberry products were used, and how doses were measured. The review did not report a single combined number of participants, so the strength of the evidence is best described as early and exploratory.
What the Results Show
The main finding is that blueberries contain several groups of plant compounds, including anthocyanins, flavanols, and phenolic acids, that appear to influence key cell signals. These signals, which include pathways called NF-κB, PI3K, Akt, and MAPK, help control whether cells grow, divide, or die. The review found that blueberry compounds may affect these signals in ways that could slow abnormal cell growth.
In lab experiments, blueberry compounds reduced the number of cancer cells that multiplied in breast, lung, ovarian, colorectal, and several other cancer types. The compounds also appeared to push cancer cells into a resting phase where they stop dividing, and to trigger apoptosis, which is the body’s natural process of programmed cell death. Think of it as the compounds helping damaged cells shut down rather than continue growing out of control.
In animal studies, diets that included blueberries or blueberry products were linked to slower tumor growth and smaller tumor size. Some experiments also suggested that blueberries may reduce tumor migration, which is how cancer cells spread, and angiogenesis, which is the formation of new blood vessels that feed tumors. These findings were seen across a similar range of cancer types as the lab studies.
Despite these promising results, the review emphasizes that the findings come from early-stage research. The authors describe the evidence as a source of promising compounds rather than proof of a health benefit in people.
The review noted that blueberry products vary widely. Fresh berries, freeze-dried powders, juices, and concentrated extracts contain different amounts of active compounds, so results from one experiment may not match another. This variation makes it harder to know which form, if any, would be most helpful.
The authors also raised concerns about bioavailability, which refers to how much of a compound the body actually absorbs and uses. Many plant compounds are broken down during digestion or processed quickly by the liver, so the amount reaching tissues may be much lower than the amount used in lab dishes. This is an important reason why lab findings cannot be assumed to apply directly to people.
Finally, the review pointed out that some cancer types have been tested in animals only a limited number of times. This means that researchers do not yet have a complete picture of blueberry effects across all cancers.
This review fits with a broader body of research on berries and plant foods that are rich in antioxidants. Earlier laboratory studies on anthocyanins and other polyphenols have also reported effects on cell growth and cell death, and this review confirms that these patterns appear across several cancer types in blueberry research specifically.
At the same time, the review reflects a common pattern in nutrition science. Many promising lab findings for plant foods have not always held up in large human studies. Because of this history, the authors call for clinical trials before blueberries can be recommended for cancer prevention or management. The review’s conclusions are consistent with that cautious approach.
The most important limitation is that there are no clinical studies in people. Without human trials, it is not possible to know whether blueberries affect cancer risk, tumor growth, or outcomes in real patients.
Animal and lab studies also have limits. Some cancer types were studied in only a small number of animal experiments, and results may not transfer well from animals to humans. The review also noted heterogeneity, meaning that the blueberry preparations used across studies differed greatly, which makes it hard to compare results directly.
Finally, bioavailability remains a concern. The body may not absorb or keep enough of these compounds at the levels needed to produce the effects seen in lab dishes. Because of these limits, the review describes its findings as early-stage and calls for future clinical trials.
The Bottom Line
Confidence level: low for any claim about cancer prevention or treatment in people. The current evidence comes from lab and animal studies, and no human trials were available to confirm the effects. Blueberries can still be included in a balanced diet because they are a nutritious food rich in fiber, vitamins, and plant compounds. Eating blueberries should be viewed as a healthy habit, not a cancer strategy. Continue following established guidance such as regular cancer screenings, maintaining a healthy weight, staying physically active, and limiting alcohol and tobacco.
People interested in healthy eating, researchers studying functional foods, and anyone curious about the early science behind berries may find this review useful. People with a family history of cancer may also want to know that these findings do not change standard screening recommendations.
People who are currently undergoing cancer treatment should not change their medical plan based on this research. Anyone considering blueberry supplements or extracts during treatment should speak with their oncology team first, since some supplements can interact with medications.
Because this review describes early-stage research, there is no established timeline for proven cancer benefits from blueberries. Human clinical trials would need to be designed, funded, and completed before doctors could recommend blueberries for cancer prevention or management. That process typically takes several years, and results may still be inconclusive.
If you choose to eat blueberries regularly, any general health benefits from a balanced diet would take weeks to months to show up in areas such as digestion or energy levels. Cancer-related benefits, if they exist, cannot be measured in your daily life and should not be expected from diet alone.
Frequently Asked Questions
Can eating blueberries prevent cancer?
Current evidence does not prove that eating blueberries prevents cancer in people. A 2026 review of lab and animal studies found promising effects on cancer cells, but no clinical trials in humans have tested whether blueberries lower cancer risk. Researchers say human studies are needed.
What compounds in blueberries are being studied for cancer?
Researchers are studying anthocyanins, flavanols, and phenolic acids, plant compounds that give blueberries their deep color. In lab studies, these compounds appeared to influence cell signals that control growth and cell death in several cancer types.
How many blueberries should I eat to help fight cancer?
A specific effective dose has not been established for cancer. The 2026 review did not identify a proven daily amount for people. Blueberries are a nutritious food that fits well in a balanced diet, but they should not replace recommended cancer screenings or treatment.
Are blueberry supplements a proven cancer treatment?
Current evidence does not support blueberry supplements as a proven cancer treatment. The review noted wide variation in blueberry preparations, which makes results hard to compare, and no clinical trials have tested them in cancer patients. Talk with your doctor before using supplements during treatment.
Want to Apply This Research?
- Log your weekly blueberry intake in cups or grams, such as one half cup of fresh or frozen blueberries per serving. Track how many servings you eat per week and aim for a consistent number, such as three to four servings, so you can see your pattern over time.
- Add blueberries to foods you already eat, such as oatmeal, plain yogurt, or a salad, rather than trying to eat large amounts at once. Frozen blueberries are affordable, keep well, and are just as nutritious as fresh ones. Set a weekly reminder in the app to check your servings.
- Review your blueberry and overall fruit and vegetable intake each month to see whether your habit is steady. Pair this with tracking of your regular health checkups and cancer screening appointments, so your diet log supports healthy habits rather than replacing medical care. Update your approach if new clinical research on blueberries is published.
This article summarizes a review of laboratory and animal studies and is for general education only. It is not medical advice. Blueberries are not a substitute for cancer screening, prevention guidance, or treatment from a qualified healthcare provider. Please consult your doctor before making changes related to cancer risk, supplements, or treatment.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.